Global Lung Cancer Drug Market Research Report 2026(Status and Outlook)

May 2026 | 175 pages | ID: GEA5FC9C671EEN
Bosson Research

Abstracts

Lung cancer drug refer to chemical or biological agents specifically used to treat lung cancer by inhibiting tumor growth, promoting cancer cell death or enhancing the body's anti-tumor ability to achieve therapeutic purposes. The core of this approach is to intervene in the biological characteristics of lung cancer cells while minimizing damage to normal tissues.

The global Lung Cancer Drug market size was estimated at USD 48910.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Lung Cancer Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Lung Cancer Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Drug market.

Global Lung Cancer Drug Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Novartis International
• AstraZeneca
• Bristol-Myers Squibb Company
• Pfizer
• Roche
• Merck
• Regeneron
• Eli Lilly
• Daiichi Sankyo
• BioNTech
• Johnson & Johnson
• Takeda
• Amgen
• Jazz Pharmaceuticals
• BeiGene
• Junshi Bio
• Qilu Pharmaceutical
• Zhengda Tianqing Pharmaceutical
• Betta Pharmaceuticals
• Nanjing Shenghe Pharmaceutical
• Guangdong Akeso Biology
• Innovent Biologics
• Shanghai Allist Medical Technology
• Shanghai Fuhong Henlius Biotechnology
• Sichuan Kelunbotai Biomedicine

Market Segmentation (by Type)

• Chemotherapeutics
• Targeted Drug
• Immunotherapy Drug

Market Segmentation (by Application)

• Preoperative Treatment
• Postoperative Treatment

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Lung Cancer Drug Market

Overview of the regional outlook of the Lung Cancer Drug Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Lung Cancer Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Lung Cancer Drug
1.2 Key Market Segments
  1.2.1 Lung Cancer Drug Segment by Type
  1.2.2 Lung Cancer Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 LUNG CANCER DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Lung Cancer Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Lung Cancer Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 LUNG CANCER DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Drug Product Life Cycle
3.3 Global Lung Cancer Drug Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Lung Cancer Drug Market Competitive Situation and Trends
  3.8.1 Lung Cancer Drug Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Lung Cancer Drug Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 LUNG CANCER DRUG INDUSTRY CHAIN ANALYSIS

4.1 Lung Cancer Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Drug Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Lung Cancer Drug Market
5.7 ESG Ratings of Leading Companies

6 LUNG CANCER DRUG MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Drug Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Drug Market Size by Type (2020-2025)
6.4 Global Lung Cancer Drug Price by Type (2020-2025)

7 LUNG CANCER DRUG MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Drug Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Drug Sales Growth Rate by Application (2020-2025)

8 LUNG CANCER DRUG MARKET SALES BY REGION

8.1 Global Lung Cancer Drug Sales by Region
  8.1.1 Global Lung Cancer Drug Sales by Region
  8.1.2 Global Lung Cancer Drug Sales Market Share by Region
8.2 Global Lung Cancer Drug Market Size by Region
  8.2.1 Global Lung Cancer Drug Market Size by Region
  8.2.2 Global Lung Cancer Drug Market Size by Region
8.3 North America
  8.3.1 North America Lung Cancer Drug Sales by Country
  8.3.2 North America Lung Cancer Drug Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Lung Cancer Drug Sales by Country
  8.4.2 Europe Lung Cancer Drug Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Lung Cancer Drug Sales by Region
  8.5.2 Asia Pacific Lung Cancer Drug Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Lung Cancer Drug Sales by Country
  8.6.2 South America Lung Cancer Drug Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Lung Cancer Drug Sales by Region
  8.7.2 Middle East and Africa Lung Cancer Drug Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 LUNG CANCER DRUG MARKET PRODUCTION BY REGION

9.1 Global Production of Lung Cancer Drug by Region(2020-2025)
9.2 Global Lung Cancer Drug Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Drug Production
  9.4.1 North America Lung Cancer Drug Production Growth Rate (2020-2025)
  9.4.2 North America Lung Cancer Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Drug Production
  9.5.1 Europe Lung Cancer Drug Production Growth Rate (2020-2025)
  9.5.2 Europe Lung Cancer Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Drug Production (2020-2025)
  9.6.1 Japan Lung Cancer Drug Production Growth Rate (2020-2025)
  9.6.2 Japan Lung Cancer Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Drug Production (2020-2025)
  9.7.1 China Lung Cancer Drug Production Growth Rate (2020-2025)
  9.7.2 China Lung Cancer Drug Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Novartis International
  10.1.1 Novartis International Basic Information
  10.1.2 Novartis International Lung Cancer Drug Product Overview
  10.1.3 Novartis International Lung Cancer Drug Product Market Performance
  10.1.4 Novartis International Business Overview
  10.1.5 Novartis International SWOT Analysis
  10.1.6 Novartis International Recent Developments
10.2 AstraZeneca
  10.2.1 AstraZeneca Basic Information
  10.2.2 AstraZeneca Lung Cancer Drug Product Overview
  10.2.3 AstraZeneca Lung Cancer Drug Product Market Performance
  10.2.4 AstraZeneca Business Overview
  10.2.5 AstraZeneca SWOT Analysis
  10.2.6 AstraZeneca Recent Developments
10.3 Bristol-Myers Squibb Company
  10.3.1 Bristol-Myers Squibb Company Basic Information
  10.3.2 Bristol-Myers Squibb Company Lung Cancer Drug Product Overview
  10.3.3 Bristol-Myers Squibb Company Lung Cancer Drug Product Market Performance
  10.3.4 Bristol-Myers Squibb Company Business Overview
  10.3.5 Bristol-Myers Squibb Company SWOT Analysis
  10.3.6 Bristol-Myers Squibb Company Recent Developments
10.4 Pfizer
  10.4.1 Pfizer Basic Information
  10.4.2 Pfizer Lung Cancer Drug Product Overview
  10.4.3 Pfizer Lung Cancer Drug Product Market Performance
  10.4.4 Pfizer Business Overview
  10.4.5 Pfizer Recent Developments
10.5 Roche
  10.5.1 Roche Basic Information
  10.5.2 Roche Lung Cancer Drug Product Overview
  10.5.3 Roche Lung Cancer Drug Product Market Performance
  10.5.4 Roche Business Overview
  10.5.5 Roche Recent Developments
10.6 Merck
  10.6.1 Merck Basic Information
  10.6.2 Merck Lung Cancer Drug Product Overview
  10.6.3 Merck Lung Cancer Drug Product Market Performance
  10.6.4 Merck Business Overview
  10.6.5 Merck Recent Developments
10.7 Regeneron
  10.7.1 Regeneron Basic Information
  10.7.2 Regeneron Lung Cancer Drug Product Overview
  10.7.3 Regeneron Lung Cancer Drug Product Market Performance
  10.7.4 Regeneron Business Overview
  10.7.5 Regeneron Recent Developments
10.8 Eli Lilly
  10.8.1 Eli Lilly Basic Information
  10.8.2 Eli Lilly Lung Cancer Drug Product Overview
  10.8.3 Eli Lilly Lung Cancer Drug Product Market Performance
  10.8.4 Eli Lilly Business Overview
  10.8.5 Eli Lilly Recent Developments
10.9 Daiichi Sankyo
  10.9.1 Daiichi Sankyo Basic Information
  10.9.2 Daiichi Sankyo Lung Cancer Drug Product Overview
  10.9.3 Daiichi Sankyo Lung Cancer Drug Product Market Performance
  10.9.4 Daiichi Sankyo Business Overview
  10.9.5 Daiichi Sankyo Recent Developments
10.10 BioNTech
  10.10.1 BioNTech Basic Information
  10.10.2 BioNTech Lung Cancer Drug Product Overview
  10.10.3 BioNTech Lung Cancer Drug Product Market Performance
  10.10.4 BioNTech Business Overview
  10.10.5 BioNTech Recent Developments
10.11 Johnson and Johnson
  10.11.1 Johnson and Johnson Basic Information
  10.11.2 Johnson and Johnson Lung Cancer Drug Product Overview
  10.11.3 Johnson and Johnson Lung Cancer Drug Product Market Performance
  10.11.4 Johnson and Johnson Business Overview
  10.11.5 Johnson and Johnson Recent Developments
10.12 Takeda
  10.12.1 Takeda Basic Information
  10.12.2 Takeda Lung Cancer Drug Product Overview
  10.12.3 Takeda Lung Cancer Drug Product Market Performance
  10.12.4 Takeda Business Overview
  10.12.5 Takeda Recent Developments
10.13 Amgen
  10.13.1 Amgen Basic Information
  10.13.2 Amgen Lung Cancer Drug Product Overview
  10.13.3 Amgen Lung Cancer Drug Product Market Performance
  10.13.4 Amgen Business Overview
  10.13.5 Amgen Recent Developments
10.14 Jazz Pharmaceuticals
  10.14.1 Jazz Pharmaceuticals Basic Information
  10.14.2 Jazz Pharmaceuticals Lung Cancer Drug Product Overview
  10.14.3 Jazz Pharmaceuticals Lung Cancer Drug Product Market Performance
  10.14.4 Jazz Pharmaceuticals Business Overview
  10.14.5 Jazz Pharmaceuticals Recent Developments
10.15 BeiGene
  10.15.1 BeiGene Basic Information
  10.15.2 BeiGene Lung Cancer Drug Product Overview
  10.15.3 BeiGene Lung Cancer Drug Product Market Performance
  10.15.4 BeiGene Business Overview
  10.15.5 BeiGene Recent Developments
10.16 Junshi Bio
  10.16.1 Junshi Bio Basic Information
  10.16.2 Junshi Bio Lung Cancer Drug Product Overview
  10.16.3 Junshi Bio Lung Cancer Drug Product Market Performance
  10.16.4 Junshi Bio Business Overview
  10.16.5 Junshi Bio Recent Developments
10.17 Qilu Pharmaceutical
  10.17.1 Qilu Pharmaceutical Basic Information
  10.17.2 Qilu Pharmaceutical Lung Cancer Drug Product Overview
  10.17.3 Qilu Pharmaceutical Lung Cancer Drug Product Market Performance
  10.17.4 Qilu Pharmaceutical Business Overview
  10.17.5 Qilu Pharmaceutical Recent Developments
10.18 Zhengda Tianqing Pharmaceutical
  10.18.1 Zhengda Tianqing Pharmaceutical Basic Information
  10.18.2 Zhengda Tianqing Pharmaceutical Lung Cancer Drug Product Overview
  10.18.3 Zhengda Tianqing Pharmaceutical Lung Cancer Drug Product Market Performance
  10.18.4 Zhengda Tianqing Pharmaceutical Business Overview
  10.18.5 Zhengda Tianqing Pharmaceutical Recent Developments
10.19 Betta Pharmaceuticals
  10.19.1 Betta Pharmaceuticals Basic Information
  10.19.2 Betta Pharmaceuticals Lung Cancer Drug Product Overview
  10.19.3 Betta Pharmaceuticals Lung Cancer Drug Product Market Performance
  10.19.4 Betta Pharmaceuticals Business Overview
  10.19.5 Betta Pharmaceuticals Recent Developments
10.20 Nanjing Shenghe Pharmaceutical
  10.20.1 Nanjing Shenghe Pharmaceutical Basic Information
  10.20.2 Nanjing Shenghe Pharmaceutical Lung Cancer Drug Product Overview
  10.20.3 Nanjing Shenghe Pharmaceutical Lung Cancer Drug Product Market Performance
  10.20.4 Nanjing Shenghe Pharmaceutical Business Overview
  10.20.5 Nanjing Shenghe Pharmaceutical Recent Developments
10.21 Guangdong Akeso Biology
  10.21.1 Guangdong Akeso Biology Basic Information
  10.21.2 Guangdong Akeso Biology Lung Cancer Drug Product Overview
  10.21.3 Guangdong Akeso Biology Lung Cancer Drug Product Market Performance
  10.21.4 Guangdong Akeso Biology Business Overview
  10.21.5 Guangdong Akeso Biology Recent Developments
10.22 Innovent Biologics
  10.22.1 Innovent Biologics Basic Information
  10.22.2 Innovent Biologics Lung Cancer Drug Product Overview
  10.22.3 Innovent Biologics Lung Cancer Drug Product Market Performance
  10.22.4 Innovent Biologics Business Overview
  10.22.5 Innovent Biologics Recent Developments
10.23 Shanghai Allist Medical Technology
  10.23.1 Shanghai Allist Medical Technology Basic Information
  10.23.2 Shanghai Allist Medical Technology Lung Cancer Drug Product Overview
  10.23.3 Shanghai Allist Medical Technology Lung Cancer Drug Product Market Performance
  10.23.4 Shanghai Allist Medical Technology Business Overview
  10.23.5 Shanghai Allist Medical Technology Recent Developments
10.24 Shanghai Fuhong Henlius Biotechnology
  10.24.1 Shanghai Fuhong Henlius Biotechnology Basic Information
  10.24.2 Shanghai Fuhong Henlius Biotechnology Lung Cancer Drug Product Overview
  10.24.3 Shanghai Fuhong Henlius Biotechnology Lung Cancer Drug Product Market Performance
  10.24.4 Shanghai Fuhong Henlius Biotechnology Business Overview
  10.24.5 Shanghai Fuhong Henlius Biotechnology Recent Developments
10.25 Sichuan Kelunbotai Biomedicine
  10.25.1 Sichuan Kelunbotai Biomedicine Basic Information
  10.25.2 Sichuan Kelunbotai Biomedicine Lung Cancer Drug Product Overview
  10.25.3 Sichuan Kelunbotai Biomedicine Lung Cancer Drug Product Market Performance
  10.25.4 Sichuan Kelunbotai Biomedicine Business Overview
  10.25.5 Sichuan Kelunbotai Biomedicine Recent Developments

11 LUNG CANCER DRUG MARKET FORECAST BY REGION

11.1 Global Lung Cancer Drug Market Size Forecast
11.2 Global Lung Cancer Drug Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Lung Cancer Drug Market Size Forecast by Country
  11.2.3 Asia Pacific Lung Cancer Drug Market Size Forecast by Region
  11.2.4 South America Lung Cancer Drug Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Drug by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Lung Cancer Drug Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Lung Cancer Drug by Type (2026-2035)
  12.1.2 Global Lung Cancer Drug Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Lung Cancer Drug by Type (2026-2035)
12.2 Global Lung Cancer Drug Market Forecast by Application (2026-2035)
  12.2.1 Global Lung Cancer Drug Sales (K MT) Forecast by Application
  12.2.2 Global Lung Cancer Drug Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Lung Cancer Drug Market Size by Type (M USD)
Table 4. Global Lung Cancer Drug Market Size by Application
Table 5. Lung Cancer Drug Market Size Comparison by Region (M USD)
Table 6. Global Lung Cancer Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Lung Cancer Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Drug as of 2025)
Table 11. Global Market Lung Cancer Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Lung Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Lung Cancer Drug Sales by Type (K MT)
Table 27. Global Lung Cancer Drug Market Size by Type (M USD)
Table 28. Global Lung Cancer Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Lung Cancer Drug Sales Market Share by Type (2020-2025)
Table 30. Global Lung Cancer Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Lung Cancer Drug Market Share by Type (2020-2025)
Table 32. Global Lung Cancer Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Lung Cancer Drug Sales (K MT) by Application
Table 34. Global Lung Cancer Drug Market Size by Application
Table 35. Global Lung Cancer Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Lung Cancer Drug Sales Market Share by Application (2020-2025)
Table 37. Global Lung Cancer Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Lung Cancer Drug Market Share by Application (2020-2025)
Table 39. Global Lung Cancer Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Lung Cancer Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Lung Cancer Drug Sales Market Share by Region (2020-2025)
Table 42. Global Lung Cancer Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Lung Cancer Drug Market Size by Region (2020-2025)
Table 44. North America Lung Cancer Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Lung Cancer Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Lung Cancer Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Lung Cancer Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Lung Cancer Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Lung Cancer Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Lung Cancer Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Lung Cancer Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Lung Cancer Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Lung Cancer Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Lung Cancer Drug Production (K MT) by Region(2020-2025)
Table 55. Global Lung Cancer Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Lung Cancer Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Lung Cancer Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Lung Cancer Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Lung Cancer Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Lung Cancer Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Lung Cancer Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis International Basic Information
Table 63. Novartis International Lung Cancer Drug Product Overview
Table 64. Novartis International Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis International Business Overview
Table 66. Novartis International SWOT Analysis
Table 67. Novartis International Recent Developments
Table 68. AstraZeneca Basic Information
Table 69. AstraZeneca Lung Cancer Drug Product Overview
Table 70. AstraZeneca Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca SWOT Analysis
Table 73. AstraZeneca Recent Developments
Table 74. Bristol-Myers Squibb Company Basic Information
Table 75. Bristol-Myers Squibb Company Lung Cancer Drug Product Overview
Table 76. Bristol-Myers Squibb Company Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Company Business Overview
Table 78. Bristol-Myers Squibb Company SWOT Analysis
Table 79. Bristol-Myers Squibb Company Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Lung Cancer Drug Product Overview
Table 82. Pfizer Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Lung Cancer Drug Product Overview
Table 87. Roche Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Merck Basic Information
Table 91. Merck Lung Cancer Drug Product Overview
Table 92. Merck Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Merck Business Overview
Table 94. Merck Recent Developments
Table 95. Regeneron Basic Information
Table 96. Regeneron Lung Cancer Drug Product Overview
Table 97. Regeneron Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Regeneron Business Overview
Table 99. Regeneron Recent Developments
Table 100. Eli Lilly Basic Information
Table 101. Eli Lilly Lung Cancer Drug Product Overview
Table 102. Eli Lilly Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Eli Lilly Business Overview
Table 104. Eli Lilly Recent Developments
Table 105. Daiichi Sankyo Basic Information
Table 106. Daiichi Sankyo Lung Cancer Drug Product Overview
Table 107. Daiichi Sankyo Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Daiichi Sankyo Business Overview
Table 109. Daiichi Sankyo Recent Developments
Table 110. BioNTech Basic Information
Table 111. BioNTech Lung Cancer Drug Product Overview
Table 112. BioNTech Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. BioNTech Business Overview
Table 114. BioNTech Recent Developments
Table 115. Johnson and Johnson Basic Information
Table 116. Johnson and Johnson Lung Cancer Drug Product Overview
Table 117. Johnson and Johnson Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Johnson and Johnson Business Overview
Table 119. Johnson and Johnson Recent Developments
Table 120. Takeda Basic Information
Table 121. Takeda Lung Cancer Drug Product Overview
Table 122. Takeda Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Business Overview
Table 124. Takeda Recent Developments
Table 125. Amgen Basic Information
Table 126. Amgen Lung Cancer Drug Product Overview
Table 127. Amgen Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Amgen Business Overview
Table 129. Amgen Recent Developments
Table 130. Jazz Pharmaceuticals Basic Information
Table 131. Jazz Pharmaceuticals Lung Cancer Drug Product Overview
Table 132. Jazz Pharmaceuticals Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Jazz Pharmaceuticals Business Overview
Table 134. Jazz Pharmaceuticals Recent Developments
Table 135. BeiGene Basic Information
Table 136. BeiGene Lung Cancer Drug Product Overview
Table 137. BeiGene Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. BeiGene Business Overview
Table 139. BeiGene Recent Developments
Table 140. Junshi Bio Basic Information
Table 141. Junshi Bio Lung Cancer Drug Product Overview
Table 142. Junshi Bio Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Junshi Bio Business Overview
Table 144. Junshi Bio Recent Developments
Table 145. Qilu Pharmaceutical Basic Information
Table 146. Qilu Pharmaceutical Lung Cancer Drug Product Overview
Table 147. Qilu Pharmaceutical Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Qilu Pharmaceutical Business Overview
Table 149. Qilu Pharmaceutical Recent Developments
Table 150. Zhengda Tianqing Pharmaceutical Basic Information
Table 151. Zhengda Tianqing Pharmaceutical Lung Cancer Drug Product Overview
Table 152. Zhengda Tianqing Pharmaceutical Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Zhengda Tianqing Pharmaceutical Business Overview
Table 154. Zhengda Tianqing Pharmaceutical Recent Developments
Table 155. Betta Pharmaceuticals Basic Information
Table 156. Betta Pharmaceuticals Lung Cancer Drug Product Overview
Table 157. Betta Pharmaceuticals Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Betta Pharmaceuticals Business Overview
Table 159. Betta Pharmaceuticals Recent Developments
Table 160. Nanjing Shenghe Pharmaceutical Basic Information
Table 161. Nanjing Shenghe Pharmaceutical Lung Cancer Drug Product Overview
Table 162. Nanjing Shenghe Pharmaceutical Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Nanjing Shenghe Pharmaceutical Business Overview
Table 164. Nanjing Shenghe Pharmaceutical Recent Developments
Table 165. Guangdong Akeso Biology Basic Information
Table 166. Guangdong Akeso Biology Lung Cancer Drug Product Overview
Table 167. Guangdong Akeso Biology Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Guangdong Akeso Biology Business Overview
Table 169. Guangdong Akeso Biology Recent Developments
Table 170. Innovent Biologics Basic Information
Table 171. Innovent Biologics Lung Cancer Drug Product Overview
Table 172. Innovent Biologics Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Innovent Biologics Business Overview
Table 174. Innovent Biologics Recent Developments
Table 175. Shanghai Allist Medical Technology Basic Information
Table 176. Shanghai Allist Medical Technology Lung Cancer Drug Product Overview
Table 177. Shanghai Allist Medical Technology Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Shanghai Allist Medical Technology Business Overview
Table 179. Shanghai Allist Medical Technology Recent Developments
Table 180. Shanghai Fuhong Henlius Biotechnology Basic Information
Table 181. Shanghai Fuhong Henlius Biotechnology Lung Cancer Drug Product Overview
Table 182. Shanghai Fuhong Henlius Biotechnology Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Shanghai Fuhong Henlius Biotechnology Business Overview
Table 184. Shanghai Fuhong Henlius Biotechnology Recent Developments
Table 185. Sichuan Kelunbotai Biomedicine Basic Information
Table 186. Sichuan Kelunbotai Biomedicine Lung Cancer Drug Product Overview
Table 187. Sichuan Kelunbotai Biomedicine Lung Cancer Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Sichuan Kelunbotai Biomedicine Business Overview
Table 189. Sichuan Kelunbotai Biomedicine Recent Developments
Table 190. Global Lung Cancer Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 191. Global Lung Cancer Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Lung Cancer Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 193. North America Lung Cancer Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Lung Cancer Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 195. Europe Lung Cancer Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Lung Cancer Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 197. Asia Pacific Lung Cancer Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Lung Cancer Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 199. South America Lung Cancer Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Lung Cancer Drug Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Lung Cancer Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Lung Cancer Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 203. Global Lung Cancer Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Lung Cancer Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 205. Global Lung Cancer Drug Sales (K MT) Forecast by Application (2026-2035)
Table 206. Global Lung Cancer Drug Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Lung Cancer Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Drug Market Size (M USD), 2025-2035
Figure 5. Global Lung Cancer Drug Market Size (M USD) (2020-2035)
Figure 6. Global Lung Cancer Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Drug Product Life Cycle
Figure 13. Lung Cancer Drug Sales Share by Manufacturers in 2025
Figure 14. Global Lung Cancer Drug Revenue Share by Manufacturers in 2025
Figure 15. Lung Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Lung Cancer Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Drug Revenue in 2025
Figure 18. Industry Chain Map of Lung Cancer Drug
Figure 19. Global Lung Cancer Drug Market PEST Analysis
Figure 20. Global Lung Cancer Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Drug Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Drug by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Drug by Type in 2025
Figure 29. Market Share of Lung Cancer Drug by Type (2020-2025)
Figure 30. Market Share of Lung Cancer Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Drug Market Share by Application
Figure 33. Global Lung Cancer Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Drug Sales Market Share by Application in 2025
Figure 35. Global Lung Cancer Drug Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Drug Market Share by Application in 2025
Figure 37. Global Lung Cancer Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Drug Market Size by Region (2020-2025)
Figure 40. North America Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Lung Cancer Drug Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Drug Market Size by Country in 2024
Figure 45. U.S. Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Lung Cancer Drug Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Drug Market Size by Country in 2024
Figure 55. Germany Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Lung Cancer Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Drug Market Size by Region in 2024
Figure 68. China Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Drug Sales and Growth Rate (K MT)
Figure 79. South America Lung Cancer Drug Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Drug Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Drug Market Size by Country in 2024
Figure 82. Brazil Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Lung Cancer Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Lung Cancer Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Drug Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Lung Cancer Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Lung Cancer Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Lung Cancer Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Lung Cancer Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Lung Cancer Drug Market Share Forecast by Application (2026-2035)